| Market Cap | 7.3B |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | 1.12 |
| Dividend Yield | - |
| D/E Ratio | 0.26 |
| Current Ratio | 3.33 |
| Market Segment | Main Board |
| Currency | CNY |
Business Overview
Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, research, develops, produces, and sells drug products in China and internationally. The company's chemical preparations include basic infusion, therapeutic infusion, liver disease medication, nervous system drugs, anti-tumor and adjuvant drugs, nutritional infusion, contrast agents, cardiovascular and cerebrovascular drugs, anti-infective drugs, narcotic analgesics, obstetrics and gynecology medication, digestive system medication, respiratory system medication, immune system drugs, and hormonal drugs. It also offers Chinese medicine preparations; complete and incomplete nutritional formula food; specific nutritionally complete formula foods; nutritious food; health food; API; and packaging products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd. and changed its name to Cisen Pharmaceutical Co., Ltd. in 2011. Cisen Pharmaceutical Co., Ltd. was founded in 1970 and is headquartered in Jining, the People's Republic of China.
Key Financial Metrics
Profitability
Returns & Efficiency
Financial Health
| Industry | Pharmaceutical Manufacturing |
| Market Segment | Main Board |
| Currency | CNY |
| Fiscal Year | 2024 |
Stock Chart
Full charting with technical indicators, candlestick, line charts, and more.
Company Profile
| Company Name | 辰欣药业 |
| Ticker | 603367 |
| Exchange | SSE |
| Sector | CSRC Classification |
| Industry | Pharmaceutical Manufacturing |
| Market Segment | Main Board |
| Fiscal Year | 2024 |
| Currency | CNY |
| Market Cap | 7.3B |
| Revenue | 4.0B |
| Net Income | 515.0M |
| P/E Ratio | - |
| EPS | 1.12 |
| Net Margin | 12.9% |
| ROE | 8.6% |
| Dividend Yield | - |
Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, research, develops, produces, and sells drug products in China and internationally. The company's chemical preparations include basic infusion, therapeutic infusion, liver disease medication, nervous system drugs, anti-tumor and adjuvant drugs, nutritional infusion, contrast agents, cardiovascular and cerebrovascular drugs, anti-infective drugs, narcotic analgesics, obstetrics and gynecology medication, digestive system medication, respiratory system medication, immune system drugs, and hormonal drugs. It also offers Chinese medicine preparations; complete and incomplete nutritional formula food; specific nutritionally complete formula foods; nutritious food; health food; API; and packaging products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd. and changed its name to Cisen Pharmaceutical Co., Ltd. in 2011. Cisen Pharmaceutical Co., Ltd. was founded in 1970 and is headquartered in Jining, the People's Republic of China.